MedX Health Names John Gevisser as Chief Executive Officer-March 2024-www.financetom.com

MedX Health Names John Gevisser as Chief Executive Officer

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

MedX Health Names John Gevisser as Chief Executive Officer

Jul 23, 2025 5:54 AM

08:24 AM EDT, 07/23/2025 (MT Newswires) -- MedX Health ( MDXHF ) overnight Tuesday appointed John Gevisser as its chief executive.

The company said Stephen Lockyer, who stepped up as a director, CEO and president in 2023, will remain as president of the company, as the CEO role gets passed over to Gevisser, who previously held the position of chief digital officer at UK's Health Partners Group.

Shares of the company closed up 6.3% to $0.085 on Tuesday on the TSX Venture Exchange.

Previous page： Jefferies Executives Say Investment Banking Separate From Fund Linked to First Brands Collapse Next page： Novartis Says 5-Year Kisqali Data Cut Early Breast Cancer Recurrence by 28%

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Jefferies Executives Say Investment Banking Separate From Fund Linked to First Brands Collapse

Oct 17, 2025

08:52 AM EDT, 10/17/2025 (MT Newswires) -- Jefferies Financial Group's ( JEF ) investment management is absolutely separate from the controversial Point Bonita fund linked to the collapse of auto parts manufacturer First Brands, Jefferies President Brian Friedman said at the bank's investor day on Thursday. The 2019 decision of Point Bonita's asset management team to engage with First Brands...

Novartis Says 5-Year Kisqali Data Cut Early Breast Cancer Recurrence by 28%

Oct 17, 2025

08:52 AM EDT, 10/17/2025 (MT Newswires) -- Novartis ( NVS ) said Friday that five-year results from the phase 3 Natalee study show Kisqali plus endocrine therapy reduced the risk of recurrence by 28% in early HR-positive or HER2-negative breast cancer versus endocrine therapy alone. The combined regimen delivered an 85.5% invasive disease-free survival rate at five years versus 81%...

Oct 17, 2025

...

Sector Update: Consumer

Oct 17, 2025

08:53 AM EDT, 10/17/2025 (MT Newswires) -- Consumer stocks were easing lower pre-bell Friday, with the Consumer Staples Select Sector SPDR Fund (XLP) 0.01% lower and the Consumer Discretionary Select Sector SPDR Fund (XLY) down 0.03%. Starbucks ( SBUX ) shareholders led by New York City's pension funds and Trillium Asset Management have asked the board to resume talks with...